Saturday, April 20, 2013 6:00 PM
|
CCSVI in Multiple Sclerosis
Dear BNAC--your blatant misrepresentation of your trial has been picked up by the New York Times, Dr. Sanjay Gupta, and even the Globe. Will you please contact these media outlets and let them know PREMiSe failed. You did not improve patients' blood flow....the placebo side had better venous hemodynamic flow. We're waiting. Signed, CCSVI advocates around the world. MS Choices Grow: What's Best for Your Patient?www.medpagetoday.com MS news dominated the American Academy of Neurology meeting in San Diego last month, but the really big news came after the meeting ended with the widely expected FDA approval of dimethyl fumarate (Te
|